Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference29 articles.
1. Scherer, F. M. The link between gross profitability and pharmaceutical R&D spending. An analysis that answers the question: what does the pharmaceutical industry really do with its profits? Health Affairs 20, 216–220 (2001).
2. US Congress, Office of Technology Assessment. Innovation and Commercialization of Emerging Technology OTA-BP-ITC–165 (Washington DC, US Government Printing Office, 1995).
3. National Research Council. Prospectus for national knowledge assessment. Committee on Knowledge Assessment Office of International Affairs (Washington DC, National Academy Press, 1996).
4. Booth, B. L. & Zemmel, R. W. The search for blockbuster drugs: efficacy isn't everything. The McKinsey Quart. 4 (2004).s
5. Wertheimer, A., Levy, R. & O'Connor, T. Too many drugs? The clinical and economic value of incremental innovations'. Investing in health: the social and economic benefits of health care innovation 14, 77–118 (2001).
Cited by
89 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献